EPIRUS Biopharmaceuticals Appoints J. Kevin Buchi to Board of Directors

Published: Jun 27, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EPIRUS Biopharmaceuticals, Inc. (EPIRUS), a privately held biotechnology company focused on the development and production of biosimilar products in and for major emerging markets, today announced the appointment of J. Kevin Buchi to its Board of Directors.

Help employers find you! Check out all the jobs and post your resume.

Back to news